227 related articles for article (PubMed ID: 21703422)
1. Human renal cell carcinoma induces a dendritic cell subset that uses T-cell crosstalk for tumor-permissive milieu alterations.
Figel AM; Brech D; Prinz PU; Lettenmeyer UK; Eckl J; Turqueti-Neves A; Mysliwietz J; Anz D; Rieth N; Muenchmeier N; Buchner A; Porubsky S; Siegert SI; Segerer S; Nelson PJ; Noessner E
Am J Pathol; 2011 Jul; 179(1):436-51. PubMed ID: 21703422
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients.
Gigante M; Mandic M; Wesa AK; Cavalcanti E; Dambrosio M; Mancini V; Battaglia M; Gesualdo L; Storkus WJ; Ranieri E
J Immunother; 2008 Apr; 31(3):254-62. PubMed ID: 18317362
[TBL] [Abstract][Full Text] [Related]
3. Heat-shock protein 70 as a tumor antigen for in vitro dendritic cell pulsing in renal cell carcinoma cases.
Meng FD; Sui CG; Tian X; Li Y; Yang CM; Ma P; Liu YP; Jiang YH
Asian Pac J Cancer Prev; 2014; 15(20):8947-50. PubMed ID: 25374234
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor response induced by vaccine of autologous dendritic/tumor fusion cells against renal cell].
Zhou J; Xia JC; Wang H; Wang QJ; Huang LX; Li YQ; Chen SP; Zhou FJ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):411-4. PubMed ID: 17974271
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
[TBL] [Abstract][Full Text] [Related]
6. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
7. Minimal recruitment and activation of dendritic cells within renal cell carcinoma.
Troy AJ; Summers KL; Davidson PJ; Atkinson CH; Hart DN
Clin Cancer Res; 1998 Mar; 4(3):585-93. PubMed ID: 9533525
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro.
Ahmed Ali HA; Di J; Mei W; Zhang YC; Li Y; Du ZW; Zhang GZ
Asian Pac J Cancer Prev; 2014; 15(2):611-6. PubMed ID: 24568466
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.
Cabillic F; Bouet-Toussaint F; Toutirais O; Rioux-Leclercq N; Fergelot P; de la Pintière CT; Genetet N; Patard JJ; Catros-Quemener V
Clin Exp Immunol; 2006 Dec; 146(3):518-23. PubMed ID: 17100773
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive effect of renal cell carcinoma on phenotype and function of dendritic cells.
Teng L; Chen Y; Ding D; Dai H; Liu G; Li C
Int Urol Nephrol; 2014 May; 46(5):915-20. PubMed ID: 24202958
[TBL] [Abstract][Full Text] [Related]
11. Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.
Kurokawa T; Oelke M; Mackensen A
Int J Cancer; 2001 Mar; 91(6):749-56. PubMed ID: 11275975
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells engineered to secrete anti-DcR3 antibody augment cytotoxic T lymphocyte response against pancreatic cancer
Chen J; Guo XZ; Li HY; Zhao JJ; Xu WD
World J Gastroenterol; 2017 Feb; 23(5):817-829. PubMed ID: 28223726
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived renal cell carcinoma cells fused with allogeneic dendritic cells elicit anti-tumor activity: in vitro results and clinical responses.
Zhou J; Weng D; Zhou F; Pan K; Song H; Wang Q; Wang H; Wang H; Li Y; Huang L; Zhang H; Huang W; Xia J
Cancer Immunol Immunother; 2009 Oct; 58(10):1587-97. PubMed ID: 19221746
[TBL] [Abstract][Full Text] [Related]
14. Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: could it be a general phenomenon?
Clavijo-Salomon MA; Ramos RN; Crippa A; Pizzo CR; Bergami-Santos PC; Barbuto JA
Cancer Immunol Immunother; 2015 Feb; 64(2):161-71. PubMed ID: 25314913
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the response of dendritic cells and regulatory T cells to tumor antigens in patients with renal cell carcinoma.
Hou MM; Chang JW; Pang ST; Chiang YJ; Shen YC; Liao SK; Hsieh JJ; Yeh KY; Chang NJ; Chuang CK
Chang Gung Med J; 2010; 33(1):25-35. PubMed ID: 20184792
[TBL] [Abstract][Full Text] [Related]
17. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
[TBL] [Abstract][Full Text] [Related]
18. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.
Subramanya S; Armant M; Salkowitz JR; Nyakeriga AM; Haridas V; Hasan M; Bansal A; Goepfert PA; Wynn KK; Ladell K; Price DA; N M; Kan-Mitchell J; Shankar P
Mol Ther; 2010 Nov; 18(11):2028-37. PubMed ID: 20648001
[TBL] [Abstract][Full Text] [Related]
19. Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart.
D' Hooghe E; Buttiglieri S; Bisignano G; Brusa D; Camussi G; Matera L
Int J Immunopathol Pharmacol; 2007; 20(4):707-17. PubMed ID: 18179743
[TBL] [Abstract][Full Text] [Related]
20. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells.
Inozume T; Hanada K; Wang QJ; Yang JC
J Immunother; 2009; 32(2):109-17. PubMed ID: 19238009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]